REACH Registration

REACH Registration

Manufacturing OTC products for the US: the cGMP

Learn about Current Good Manufacturing Practices (cGMP) regulations, how they ensure high quality products, and the consequences of non-compliance. Understand which parts of the manufacturing process are regulated and when products need to adhere to cGMPs.
REACH Registration

Negotiations between FDA and cosmetics industry groups end in dispute

Deputy Commissioner Michael Taylor of the FDA expresses disappointment at lack of compromise in updating regulations for cosmetic ingredients, potentially harming American consumers. Industry groups refute claims, highlighting the need for regulation in a largely self-regulated industry.
REACH Registration

Temporary draft revision for K-REACH regulation

The Korean Ministry of Environment has proposed a temporary adjustment to K-REACH regulations to address potential supply chain shortages. This includes simplified registration for new chemical substances and relaxed rules for research and development exemptions until December 2021.
REACH Registration

The decline of animal testing

ECHA's report highlights a growing trend in using alternatives to animal testing for chemical toxicity, with increased implementation of read-across and in vitro methods. This aligns with REACH's goals and is notably advancing in Vietnam with government support.
REACH Registration

EFSA publication on new methodology to identify chemical risks in the food and feed chain

A proposed two-year pilot study aims to develop a system for detecting harmful chemicals, prioritizing those most dangerous based on EU industrial data and environmental models. The study will initially identify known chemicals in the food chain, expanding to hundreds in later stages.
REACH Registration

New draft bill created to help improve EPA’s ability to monitor TSCA

The challenges and proposed improvements for a new regulatory bill, highlighting issues with current substance monitoring protocols and deadlines. Suggestions include clearer language, prioritization of substances, and detailed agency deadlines, though concerns about feasibility remain.